University of Patras
Μεταλλικές ενδοπροθέσεις που απελευθερώνουν φαρμακευτικές ουσίες στο ενδαγγειακό μοντέλο φλεβών κονίκλου
Abstract
dc:descriptionObjectivesThis protocol was designed to evaluate the safety and feasibility of drug-eluting stents (DES)implantation, as well as to compare their long-term results vs. bare-metal stents (BMS) in arabbit venous model, using Frequency-Domain Optical Coherence Tomography (FD-OCT).MethodsThirteen New Zealand white rabbits underwent implantation of a Zotarolimus-eluting stent inthe iliac vein (Group DES) and a BMS in the contralateral iliac vein (Group BMS). Study’sprimary endpoints included technical success and the comparison of in-stent neointimalhyperplasia in the two study groups using ex vivo FD-OCT, at 3 months.ResultsThirteen DES and 13 BMS were successfully implanted. Technical success rate was 100%(26/26 stents). Three animals (3/13, 23.0%) died within the first 45 days. The remaining 10/13animals (77%) were euthanized at the 90th day following stent implantation. The 20 stentswere successfully removed. Successful ex vivo FD-OCT was performed in all stent-implantediliac vein segments; 10 in group DES and 10 in group BMS. There was no statisticallysignificant difference in the mean neointimal thickness (NIT) between the two groups(3.02±1.19mm² in group DES vs. 2.76±1.17mm² in group BMS; p=0.0501).ConclusionsIn this experimental protocol, DES application in the venous system was safe and feasible.Hyperplasia thickness was similar in both groups after 3 months follow-up.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kitrou, Panagiotis
- Κίτρου, Παναγιώτης
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/35538